How Decentralized Clinical Trials Can Improve Data And Save Money

Decentralized clinical trials are revolutionizing research by accelerating timelines, improving data collection, and enhancing patient retention. As clinical trial durations increase due to complex treatments and regulations, mobile vision assessments provide a solution. By bringing ophthalmic evaluations directly to patients, decentralized trials can save 3-6 months on data collection, achieve up to 3x faster completion rates, and generate 14x greater profits in Phase 3 trials. 20/20 Onsite’s Mobile Vision Clinics enhance efficiency by offering pre-screening, reducing patient travel burdens, and expanding trial reach across 48 states.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.